does glp 1 cause insulin resistance GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Glucagon-like peptide-1 receptor agonists and
Description
Lets simplify it
Some of the dual and triple agonists have already shown initial successes in clinical trials, although the molecular mechanisms underlying their multiplexed pharmacology remain elusive
@Carnivore_BTC @ethanjweiss @US_FDA @LillyPad One ongoing mystery in the GLP-1 space is @US_FDA perpetuation of the black box warning for MTC, in the absence of any scientific evidence that this is warranted
GLP-1 receptor agonist therapy no longer requires insurance coverage or expensive clinic visits
Glad they finally addressed gum
Diarrhea affects up to 25% of people taking Zepbound or tirzepatide
